Status:
UNKNOWN
Anogenital Distance Differences Between Transgender Males and Female Individuals
Lead Sponsor:
Uludag University
Conditions:
Sexual Orientation Conflict Disorder
Eligibility:
FEMALE
18-50 years
Brief Summary
This study evaluates the anogenital distance measurement differences between transgender male individuals and normal healthy female individuals. Half of the participants will be selected from the men ...
Detailed Description
There is considerable evidence in human beings and in animal models supporting that anogenital distance as a sensitive biomarker of prenatal androgen reflection of reproductive health and sexual orien...
Eligibility Criteria
Inclusion
- Individuals who are 18-50 years old.
- Healthy transgender male individuals whose gender identity (Male) are different from their birth-assigned sex (Female). The participants will be invited to the study at the time of medico-legal evaluation before the sex reassignment surgery.
Exclusion
- Individuals who are older than 50 (People older than 50 cannot change their gender legally in Turkey).
- Other sexual orientation disorders. (Lesbian, Gay, Bisexual, Queer, Intersex, or Asexual persons)
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 15 2020
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03789331
Start Date
April 1 2019
End Date
March 15 2020
Last Update
April 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uludag University Hospital, Department of Obstetrics and Gynecology
Bursa, Ozluce, Turkey (Türkiye), 16059